Events & Presentations
October 21st to 23rd, Berlin
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
Dr. Slawin’s address, “Building on the Foundation of Four: Advancing Mitochondrial‑Targeted Geropeptide Medicine” will directly follow Dr. Hazel H. Szeto’s historic keynote address, “From Mitochondrial Discovery to Approved Therapy: Lessons…
May 14th-17th 2026 - Lighthaven, Berkeley CA
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
Vitalist Bay Deep Dive Pitches May 15th, 2026 05:30PM to 06:30PM Vitalist Bay – Longevity’s New Capital
June 5th, 2026 - Royal Sonesta New Orleans
Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
Platform Technologies Panel: Obesity & Cardiovascular-Kidney-Metabolic Disease Kevin Slawin, M.D., Founder and CEO Eos SENOLYTIX Presentation to Follow Panel Participation: 01:30 PM, 5th of June - Track B - Room...
September 16 - 19, 2025, Rome, Italy
Presenter: Kevin Slawin, M.D., Founder and CEO, Eos SENOLYTIX
Phaedon Institute is honored to co-host the 2nd Senotherapeutics Summit alongside the 10th Annual ICSA Conference. This landmark gathering will take place September 16th–19th at the prestigious National Research Council (CNR) in Rome, Italy. Bringing…
© 2026 Perseus SENOLYTIX.